Adaptive Biotechnologies ended 2025 with $240.2 million in cash, cash equivalents, and marketable securities. The company achieved positive Adjusted EBITDA of $4.1 million for the fourth quarter, ...

Nocturnal symptoms and musculoskeletal pain are filtered through relapse fear, driving repetitive interpretation of ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics ...

Learn how SEBI regulations shape derivatives trading in India, including position limits, intraday rules, and what they mean ...

Your daily dose of the most interesting uptrends and downtrends on the ASX with technical analysis from an expert.

Your daily dose of the most interesting uptrends and downtrends on the ASX with technical analysis from an expert.

If you're not familiar with required minimum distributions (RMDs) and their rules, it could cost you a lot. It's smart to get savvy about RMDs, even if your retirement is years away. Here's a brief ...

Objectives Female sex and anticitrullinated protein antibodies (ACPA) are associated with higher disease activity in ...

My Top 15 dividend growth stocks for February 2026 offer a 1.52% yield. Click here to read more about the list.

Neutral editorial coverage examining institutional commentary, healthcare sector context, and index association surrounding a respiratory medical technology provider within established United States ...

ResMed founder Dr. Peter Farrell has received the Horatio Alger Award, recognizing his contributions to respiratory care and medical devices. The award highlights ResMed's role in addressing sleep ...

ResMed Inc. (NYSE:RMD) reported better-than-expected second-quarter earnings on Thursday, as the sleep and respiratory care device maker posted strong revenue growth a ...